β¨ Medicines Consent Notices
23 DECEMBER 2004
NEW ZEALAND GAZETTE, No. 175
4409
Product:
Zaditen
Active Ingredient:
Ketotifen fumarate 345Β΅g/mL equivalent to ketotifen 250Β΅g/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Excelvision, La Lombardiere Industrial Zone, Annonay Cedex, France
Dated this 16th day of December 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8592
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
Product:
Pearl Drops Beauty Pearls Gloss Tooth Whitener
Active Ingredient:
Sodium fluoride 0.221%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Wilson Foods Limited
Manufacturer:
Carter Products Limited, Folkestone, Kent, England
Dated this 16th day of December 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8595
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Copegus
Active Ingredient:
Ribavirin 200mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturers:
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
Product:
Enbrel
Active Ingredient:
Etanercept 25mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Wyeth (NZ) Limited
Manufacturer:
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Dated this 16th day of December 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8594
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Aldurazyme
Active Ingredient:
Laronidase-rch 0.58mg/mL
Dosage Form:
Concentrate for infusion
New Zealand Sponsor:
Medra Services Limited
Manufacturer:
BioMarin Pharmaceutical Inc, Novato, California, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 16th day of December 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8593
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2004, No 175
Gazette.govt.nz —
NZ Gazette 2004, No 175
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of Zaditen
π₯ Health & Social Welfare16 December 2004
Medicines, Consent, Zaditen, Ketotifen fumarate, Eye drops
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of Pearl Drops Beauty Pearls Gloss Tooth Whitener
π₯ Health & Social Welfare16 December 2004
Medicines, Consent, Pearl Drops Beauty Pearls Gloss Tooth Whitener, Sodium fluoride, Toothpaste
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare16 December 2004
Medicines, Consent, Copegus, Ribavirin, Enbrel, Etanercept
- DON MATHESON, Deputy Director-General, Public Health
π₯ Provisional Consent to the Distribution of Aldurazyme
π₯ Health & Social Welfare16 December 2004
Medicines, Provisional Consent, Aldurazyme, Laronidase-rch, Concentrate for infusion
- DON MATHESON, Deputy Director-General, Public Health